SCHEMBL507063

SCHEMBL507063

CC(N)Oc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.43
POLB P06746 1/20 0.43
KDM4E B2RXH2 1/20 0.42
MAOA P21397 3/20 0.42
PTGS1 P23219 1/20 0.42
LMNA P02545 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
LTA4H P09960 1/20 0.41
TSHR P16473 1/20 0.41
SLC6A2 P23975 2/20 0.41
TAAR1 Q96RJ0 2/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
CYP2A6 P11509 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
CYP1A2 P05177 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309913 1.00 CA4 (0.43) CA4POLBKDM4EMAOAPTGS1
Hydrochloric Acid SCHEMBL28234445 0.97 POLB (0.42) CA4POLBKDM4EMAOAPTGS1
SCHEMBL9487460 0.91 LTA4H (0.52) MAOALTA4HTSHR
Acetic Acid SCHEMBL359202 0.89 MTNR1A (0.51) POLBLMNAMTNR1AMTNR1BTSHR
SCHEMBL7052665 0.86 CYP1A2 (0.58) MAOATAAR1CYP1A2GAACYP2C9
Benzamide SCHEMBL1567388 0.82 PARP10 (0.58) POLBMTNR1AMTNR1BTSHRCYP1A2
SCHEMBL7651909 0.82 TAAR1 (0.44) KDM4EPTGS1MTNR1AMTNR1BTAAR1
SCHEMBL8638375 0.81 LTA4H (0.57) MAOALTA4HSLC6A2TAAR1SLC6A4
SCHEMBL9819194 0.80 KDM4E (0.41) CA4POLBKDM4EMAOAPTGS1
SCHEMBL13451617 0.80 POLB (0.41) CA4POLBKDM4EMAOAPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 953 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116251473-A Nanofiltration membrane preparation method utilizing micro-monomer pre-reaction 浙江理工大学 2023-06-13 CN claimed
CN-115745457-A High-adaptability concrete superplasticizer, preparation method and application thereof 南京博特新材料有限公司 2023-03-07 CN claimed
CN-115725035-A Slump-retaining concrete superplasticizer, preparation method and application thereof 博特新材料泰州有限公司 2023-03-03 CN claimed
US-20220194969-A1 METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2022-06-23 US claimed
CN-113563238-A 2-phenoxyethylamino cyclohexane sulfonamide compound and preparation method and application thereof 沈阳农业大学 2021-10-29 CN claimed
WO-2020130592-A1 METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME 서울대학교산학협력단 2020-06-25 WO claimed
US-20190119415-A1 GRAFT COPOLYMER FOR CATION-EXCHANGE CHROMATOGRAPHY MERCK PATENT GMBH (DE) 2019-04-25 US claimed
US-20170296532-A1 COMPOSITIONS FOR CONTROL OF DRUG ABUSE KYDES PHARMACEUTICALS (US) 2017-10-19 US claimed
EP-2152405-B2 GRAFT COPOLYMER FOR CATION-EXCHANGE CHROMATOGRAPHY MERCK PATENT GMBH (DE) 2017-04-05 EP claimed
US-20150238497-A1 STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA INC. 2015-08-27 US claimed
US-5276192-A Preparation of phenoxyethanamines TEXACO CHEMICAL COMPANY (US) 1994-01-04 US claimed
EP-0355598-B1 BETA-PHENOXYETHYL AMINES AND THEIR USE IN THE PREPARATION OF DYES BAYER AG (DE) 1993-06-16 EP claimed
US-5126481-A Cyclization, reduction, decyclization BAYER AKTIENGESELLSCHAFT (DE) 1992-06-30 US claimed
EP-0331943-B1 PHENOXYETHYLAMINE DERIVATIVES, PROCESS FOR PREPARING THE SAME, AND COMPOSITION FOR EXHIBITING EXCELLENT ALPHA-1-BLOCKING ACTIVITY CONTAINING THE SAME Hokuriku Pharmaceutical Co.,Ltd (JP) 1992-06-17 EP claimed
EP-0429314-A2 Phenoxyalkylamine and agricultural and horticultural bactericide MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1991-05-29 EP claimed
US-4971990-A HYPOTENSIVE AGENTS, DYSUREA HOKURIKU PHARMACEUTICAL CO., LTD. (JP) 1990-11-20 US claimed
EP-0357310-A1 Process for producing substituted phenoxyethylamines and intermediates UBE INDUSTRIES, LTD. (JP) 1990-03-07 EP claimed
EP-0355598-A2 Beta-phenoxyethyl amines and their use in the preparation of dyes BAYER AG (DE) 1990-02-28 EP claimed
EP-0331943-A1 Phenoxyethylamine derivatives, process for preparing the same, and composition for exhibiting excellent alpha-1-blocking activity containing the same Hokuriku Pharmaceutical Co.,Ltd (JP) 1989-09-13 EP claimed
EP-0226475-A1 Diphenoxyethyl amine derivatives, process for their preparation and pharmaceutical compositions containing them Albert ROLLAND S.A. Société dite (FR) 1987-06-24 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220194969-A1 METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME HCN4, SLC46A1, FES CA4 1438/4885POLB 2638/4885KDM4E 2937/4885
US-20150238497-A1 STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ALDH1A2, STARD3, TXNRD2 CA4 4564/4885POLB 1562/4885KDM4E 3134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.